Clinical Trials Browser

Unknown × Capecitabine × Clear all

NCT04309578 2024-02-28

A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC

Phase 2 Unknown

Adenocarcinoma

NCT03500380 2024-02-20

A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

Phase 2/3 Unknown

Breast Diseases, Breast Neoplasms

NCT03818685 2024-02-12

BreastImmune03

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04844385 2024-02-09

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05980689 2024-02-07

Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Locally Advanced Rectal Cancer

NCT04400695 2024-01-24

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

Phase 3 Unknown

Breast Neoplasms

NCT06202014 2024-01-19

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT06194981 2024-01-12

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

Gastrointestinal

Stomach Neoplasms

NCT05859477 2024-01-02

NIVOFGFR2

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT04395989 2023-12-22

FUTURE-SUPER

Phase 2 Unknown

Triple Negative Breast Neoplasms

NCT06169202 2023-12-13

A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients

Gastrointestinal

Fruquintinib

NCT05578287 2023-12-07

DETECT

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT06156761 2023-12-05

Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer

Phase NA Unknown

Breast Neoplasms

NCT03729687 2023-11-30

LARCT-US

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT03451370 2023-11-29

COBRA

Gastrointestinal

Elderly Metastatic Colorectal Cancer Patients

NCT05262335 2023-11-28

ALTER-G-001

Phase 2 Unknown

Gastrointestinal

Digestive System Neoplasms

NCT05512520 2023-11-18

EC-CRT-003

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04310176 2023-11-13

REVOLUTION

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT05307198 2023-10-10

RAIC

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT00958737 2023-09-29

IDEA

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT03691051 2023-09-25

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

Phase 2 Unknown

HER2 Positive Metastatic Breast Cancer

NCT05176964 2023-09-25

Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer

Gastrointestinal

Rectal Neoplasms

NCT06015100 2023-08-29

Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis

Phase NA Unknown

Breast Neoplasms

NCT04262804 2023-08-22

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

Phase 2 Unknown

Breast Cancer Metastatic

NCT05415917 2023-08-22

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT04262687 2023-08-18

POCHI

Phase 2 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

NCT04156698 2023-08-09

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

Phase 2 Unknown

Hypopharyngeal Neoplasms

NCT05974059 2023-08-03

Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Locally Advanced Unresectable Gastric Adenocarcinoma

NCT04262635 2023-08-02

C-CLASSIC

Phase 3 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT03950154 2023-08-01

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT05845138 2023-08-01

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

Phase 1/2 Unknown

Breast Neoplasms

NCT05964543 2023-07-28

The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

Phase 1/2 Unknown

Adenocarcinoma, Neoplasms

NCT05965154 2023-07-28

Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

NCT04304352 2023-06-28

VEX

Phase 2 Unknown

Advanced Breast Cancer

NCT02560298 2023-06-22

InterAACT

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT04072107 2023-06-18

EP-STAR

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT05799820 2023-05-25

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT02288195 2023-05-12

CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients

Phase 3 Unknown

Gastrointestinal

Rectal Neoplasms

NCT05833919 2023-04-27

Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms

NCT03613181 2023-04-24

ANGLeD

Phase 3 Unknown

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

NCT04522284 2023-03-29

PRECISE CURATE.AI Pilot Clinical Trial

Phase 1/2 Unknown

Waldenstrom Macroglobulinemia, Neoplasms

NCT01898104 2023-03-24

V-shoRT-R3

Phase 1/2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT04942899 2023-03-01

Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT05549466 2023-02-08

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT05659290 2023-01-06

Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT03775525 2022-12-23

GEN602

Phase 1 Unknown

BreastDermatologicGastrointestinalHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Basal Cell, Colonic Neoplasms, Lymphoma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT04001621 2022-12-08

Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT05608785 2022-11-08

Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes

Phase 1/2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT05390476 2022-11-04

Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial

Phase 2 Unknown

Triple Negative Breast Neoplasms

NCT05411380 2022-11-04

Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

Phase 2 Unknown

Breast Neoplasms